Invus Financial Advisors, LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invus Financial Advisors, LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2021$1,599,000
-51.3%
1,094,9980.0%0.49%
-44.8%
Q3 2021$3,285,000
-35.3%
1,094,9980.0%0.88%
-13.0%
Q2 2021$5,081,000
-22.7%
1,094,9980.0%1.01%
-32.8%
Q1 2021$6,570,000
+14.5%
1,094,9980.0%1.51%
-37.2%
Q4 2020$5,738,000
+51.4%
1,094,9980.0%2.40%
+31.5%
Q3 2020$3,789,000
-80.1%
1,094,998
-50.0%
1.82%
-73.5%
Q2 2020$19,009,000
+49.7%
2,189,9980.0%6.87%
+10.2%
Q1 2020$12,702,000
-19.6%
2,189,9980.0%6.24%
-22.1%
Q4 2019$15,790,0002,189,9988.01%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders